Clinical Trials Browser

Phase 1/2 × Carcinoma, Renal Cell × Gemcitabine × Clear all

NCT00121251 2021-04-06

Sorafenib, Gemcitabine, and Capecitabine in Treating Patients With Unresectable and/or Metastatic Kidney Cancer

Phase 1/2 Completed

17 enrolled 13 charts

Carcinoma, Renal Cell